By December 31, Lu Daopei Hospital completed a total of 1081 cases of hematopoietic stem cell transplantation in China in 2019 and has treated approximately 800 patients by using CAR-T technology in clinical treatment.

4 Oral reports and 6 posters in the 61st ASH

The cooperation platform of the Institute of Biophysics of the Chinese Academy of Sciences, Beijing Win-win Biotech limited company and Lu Daopei hospital was officially launched.

Beijing Lu Daopei hospital successfully passed the GCP certification.

Academician Lu Daopei was awarded the "Celebrating the 70th Anniversary of the Founding of the People's Republic of China" Commemorative Medal

The 7th Lu Daopei Hematology Summit Forum was successfully held and V Love Charity Dinner was grandly opened International Regenerative Medicine Foundation awarded Lu Daopei Medical Group the "Stem Cell and Regenerative Medicine Action Award"

Lu Daopei Medical Group Synarc Lab Zero Rectification Passed CAP Certification

First successful AML patient with CD 123 CAR-T bridge BMT

Hebei Yanda Lu Daopei Hospital Receives the highest honor"AAA Credit Evaluation" and "Five-Star Hospital"

By December 31, Lu Daopei Hospitalcompleted a total of 773 cases of hematopoietic stem cell transplantation in China in 2019 and has treated approximately 500 patients by using CAR-T technology in clinical treatment.

Won the 2019 International Achievement Award

Oral reports and posters in the 60th ASH

Participated in the 23rd APBMT

Participated in the 5th International Society for Blood and Bone Marrow Transplantation

In July 2018, Lu Daopei Hospital successfully passed the GCP certification.

Joint Research Center for Hematological Oncology was established by Lu Daopei Hospital and Tsinghua University

By August 2017, Hebei Yanda Lu Daopei Hospital has treated approxim- ately 220 patients by using CAR-T tec- hnology in clinical treatment.

Beijing Lu Daopei Hospital is complet- ed and will open soon.

The 5th Lu Daopei Hematology Summit Forum

Charitable Donation by Caring Patients

The Establishment of Asia’s Largest Hematology Laboratory

The Establishment of the Telemedical Consultation Center

Successful Haplo-HSCT for a 69-year -old patient

The 4th Lu Daopei Hematology Summit Forum

The Lifetime Achievement Award to Professor Lu Daopei

The Distinguished Service Award to Professor Lu Daopei

Took Leading Position in Transplantation for Aplastic Anemia

Outstanding academic results were presented at the European Bone Marrow Transplant Annual Meeting (EBMT), the Asia-Pacific Bone Marrow Transplantation Annual Meeting (APBMT), the European hematology Association (EHA), and the American hematology academic year (ASH)

Lu Daopei Hematology and Oncology Center was renamed Heibei Yanda Lu Daopei Hospital

CAR-T technology was adopted in the treatment of B-cell acute lymphoblastic leukemia (B-ALL), lymphoma, multiple myeloma and other malignant blood diseases in July 2015.

The 3 ^rd Lu Daopei Hematology Summit Forum

Won the 2014 National Excellent Priv- ate Hospital

We completed 600th HSCT cases su-
ccessfully

The 2nd Lu Daopei Hematology Sum-
mit Forum

The world's oldest (65-year-old) unrel- ated HSCT patient was discharged su- ccessfully.

Establishment of Lu Daopei Hematol- ogy and Oncology Center

Establishment of Social Service Dep-
artment to help patients search for d-
onors from bone marrow banks

The 1st Lu Daopei Forum and the Symposium of Blood Disease Diagnosis and Treatment Development

The 100th HSCT case was completed successfully.